Tropical mountain blackberry, widely consumed in Costa Rica, is rich in ellagitannins (ETs) such as ellagic acid (EA), which are metabolized by the intestinal microbiota into urolithins after ingestion.
Objective
This study aimed to characterize the urinary excretion kinetics of urolithins in healthy Costa Rican volunteers following the intake of a blackberry-based drink, thereby contributing to the biopharmaceutical understanding of these compounds.
Methods
Fifteen healthy non-smoking male volunteers (aged 18–35 years) consumed 500 ml of water and, on a separate day, 500 ml of a blackberry-based drink (33.3%) at breakfast. Urine samples were collected at 0–6 h, 6–12 h, and 12–24 h intervals and analyzed using Ultra-Performance Liquid Chromatography coupled to Mass Spectrometry (UPLC/ESI-Q-TOF-MS). Targeted metabolomic analysis was performed to detect urolithins and related metabolites. Participants were classified according to urolithin production capacity (metabotypes A/B). All volunteers produced either one or both urolithins.
Results
In the first 6 h, significant differences in metabolomic profiles were observed, although not attributable to urolithins; instead, a presumed decrease in glucuronidated hydroxyprogesterone (HPG) and tetrahydroxycortisone (THC) metabolites was identified. Between 6–12 h, urolithins A (UA) and C (UC) were identified as the main contributors to group differences. In the 12–24 h fraction, increased excretion of UA, UC, and urolithin B (UB) was observed. Quantitatively, UA was detected in 73% of participants, UC in 60%, and UB in 47%.
Conclusions
The observed reduction in metabolites putatively identified as HPG and THC may indicate, though not confirm, potential hypolipidemic or hormone-related anticancer effects of ET-rich foods. The delayed appearance of UA and UC (6–12 h) could reflect slower gastric emptying and intestinal transit, while the presence of UB up to 24 h may indicate enterohepatic recirculation of UA conjugates. These findings provide new evidence on the metabolic fate of blackberry-derived ETs, highlight plausible biomarkers of consumption, and support the functional potential of berry-based foods in human health.
Fallas-RamirezJMBaltodano-VialesEMora-RománJJ, et al.Metabolomic screening and urolithins metabotypes identification in the urinary metabolome of Costa Rican volunteers after blackberry (Rubus adenotrichos)-based drink consumption. J Berry Res2024; 14: 175–191.
2.
Acosta-MontoyaÓVaillantFCozzanoS, et al.Phenolic content and antioxidant capacity of tropical highland blackberry (Rubus adenotrichus Schltdl.) during three edible maturity stages. Food Chem2010; 119: 1497–1501.
3.
WilhelmsenAKaragounisLGBennettAJ, et al.The polyphenol metabolite urolithin A suppresses myostatin expression and augments glucose uptake in human skeletal muscle cells. Nutr Metab (Lond)2025; 22: 12.
4.
LuCLiXGaoZ, et al.Urolithins and intestinal health. Drug Discov Ther2022; 16: 105–111.
5.
TuHJSuCJPengCS, et al.Urolithin A exhibits a neuroprotective effect against Alzheimer’s disease by inhibiting DYRK1A activity. J Food Drug Anal2023; 31: 358–370.
6.
HassanHAYousefMI. Mitigating effects of antioxidant properties of black berry juice on sodium fluoride induced hepatotoxicity and oxidative stress in rats. Food Chem Toxicol2009; 47: 2332–2337.
7.
AbdulrahmanAOAlzubaidiMYNadeemMS, et al.Effects of urolithins on obesity-associated gut dysbiosis in rats fed on a high-fat diet. Int J Food Sci Nutr2021; 72: 923–934.
8.
Garcia-MuñozCVaillantF. Metabolic fate of ellagitannins: implications for health, and research perspectives for innovative functional foods. Crit Rev Food Sci Nutr2014; 54: 1584–1598.
9.
Schmidt-DuránARodríguez-MonroyMAcosta-MontoyaO. Tropical highland blackberry (Rubus adenotrichos Schltdl.) as a potential functional food: a review of research conducted. Tecnol Marcha2024; 37(1): 128–148.
10.
Ochoa ERSánchez REPVal TCÁ, et al.Physicochemical properties of wild Rubus fruits with nutraceutical and nutritional potential. Rev Mexicana Cienc Agríc2019; 10: 291–301.
11.
Tomás-BarberánFASelmaMVEspínJC. Interactions of gut microbiota with dietary polyphenols and consequences to human health. Curr Opin Clin Nutr Metab Care2016; 19: 471–476.
12.
BobowskaAGranicaSFilipekA, et al.Comparative studies of urolithins and their phase II metabolites on macrophage and neutrophil functions. Eur J Nutr2021; 60: 1957–1972.
13.
Iglesias-AguirreCEGarcía-VillalbaRBeltránD, et al.Gut bacteria involved in ellagic acid metabolism to yield human urolithin metabotypes revealed. J Agric Food Chem2023; 71: 4029–4035.
14.
AbdelazeemKNMKaloMZBeer-HammerS, et al.The gut microbiota metabolite urolithin A inhibits NF-κB activation in LPS stimulated BMDMs. Sci Rep2021; 11: 7117.
15.
Cortés-MartínAGarcía-VillalbaRGonzález-SarríasA, et al.The gut microbiota urolithin metabotypes revisited: the human metabolism of ellagic acid is mainly determined by aging. Food Funct2018; 9: 4100–4106.
16.
Cortés-MartínAColmenarejoGSelmaMV, et al.Genetic polymorphisms, Mediterranean diet and microbiota-associated urolithin metabotypes can predict obesity in childhood-adolescence. Sci Rep2020; 10: 7850.
17.
WangCWangZXueS, et al.Urolithin A alleviates neuropathic pain and activates mitophagy. Mol Pain2023; 19: 17448069231190815.
18.
GhoshSSinghRGoapTJ, et al.Inflammation-targeted delivery of urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis. J Nanobiotechnol2024; 22: 01.
19.
HuangXGaoHJiangX, et al.Urolithin B, a Gut microbiota metabolite, reduced susceptibility to myocardial arrhythmic predisposition after hypoxia. Dis Markers2022; 2022: 6517266.
20.
AhsanAZhengYRWuXL, et al.Urolithin A-activated autophagy but not mitophagy protects against ischemic neuronal injury by inhibiting ER stress in vitro and in vivo. CNS Neurosci Ther2019; 25: 976–986.
21.
WangMYuL. Emerging evidence of Urolithin A in sports nutrition: bridging preclinical findings to athletic applications. Front Nutr2025; 12: 1585922.
22.
RibeiroMAlvarengaLCardozoLFMF, et al.Urolithin as a metabolite of ellagitannins and ellagic acid from fruits and nuts produced by the gut microbiota: its role on non-communicable diseases. Curr Nutr Rep2025; 14: 55.
23.
TrapaliMLagouriV. Urolithins – gut microbial metabolites with potential health benefits. Open Med Chem J2025; 19: e18741045375825.
24.
ManachCHubertJLlorachR, et al.The complex links between dietary phytochemicals and human health deciphered by metabolomics. Mol Nutr Food Res2009; 53: 1303–1315.
25.
EmanuelIBCooperstoneJHandFP. Ultra-high performance liquid chromatography-tandem mass spectrometry identification of metabolites in winterberry fruit putatively associated with natural disease resistance to Diaporthe ilicicola. Phytopathology2024; 114: 93–101.
26.
VaillantFPérezAMAcostaO, et al.Turbidity of pulpy fruit juice: a key factor for predicting cross-flow microfiltration performance. J Membr Sci2008; 325: 404–412.
27.
MarulandaMLópezAMUribeM. Molecular characterization of the Andean blackberry (Rubus glaucus) using SSR markers. Genet Mol Res2012; 11: 322–331.
28.
PadmavathiRShirishaKSamadMA, et al.Comparative evaluation of aqueous extracts of peel, seed and whole fruit of Punica granatum L. on ethylene glycol induced urolithiasis in rats. Int J Pharm Pharm Res2020; 19: 33–45.
29.
SelmaMVBeltránDLunaMC, et al.Isolation of human intestinal bacteria capable of producing the bioactive metabolite isourolithin a from ellagic acid. Front Microbiol2017; 8: 1521.
30.
Romo-VaqueroMGarcía-VillalbaRGonzález-SarríasA, et al.Interindividual variability in the human metabolism of ellagic acid: contribution of Gordonibacter to urolithin production. J Funct Foods2015; 17: 785–791.
31.
KorczakMRoszkowskiPGranicaS, et al.Conjugates of urolithin A with NSAIDs, their stability, cytotoxicity, and anti-inflammatory potential. Sci Rep2022; 12: 11676.
32.
SelmaMVRomo-VaqueroMGarcía-VillalbaR, et al.The human gut microbial ecology associated with overweight and obesity determines ellagic acid metabolism. Food Funct2016; 7: 1769–1774.
33.
PrabuSLSuriyaprakashTNKRuckmaniK, et al.Biopharmaceutics and pharmacokinetics. In: AhmedTA (ed) Basic Pharmacokinetic: Concepts and Some Clinical Applications. London: IntechOpen Limited, 2015.
RyouMStylopoulosN. Endoscopic ultrasound-guided sampling and profiling of portal circulation in human patients for metabolic research studies and biomarker assessment. Am J Physiol - Gastrointest Liver Physiol2020; 319: G584–G588.
36.
KnightsKMMinersJO. Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators. Drug Metab Rev2010; 42: 63–73.
37.
KnightsKMSpencerSMFallonJK, et al.Scaling factors for the in vitro–in vivo extrapolation (IV–IVE) of renal drug and xenobiotic glucuronidation clearance. Br J Clin Pharmacol2016; 81: 1153–1164.
38.
RongYTuYYinT, et al.Rapid intestinal glucuronidation and hepatic glucuronide recycling contributes significantly to the enterohepatic circulation of icaritin and its glucuronides in vivo. Arch Toxicol2020; 94: 3737–3749.
39.
StellaardFLütjohannD. Dynamics of the enterohepatic circulation of bile acids in healthy humans. Am J Physiol - Gastrointest Liver Physiol2021; 321: G55–G66.
40.
SørensenKKSimon-SantamariaJMcCuskeyRS, et al.Liver sinusoidal endothelial cells. Compr Physiol2011; 5: 1751–1774.
41.
WangPJiaYWuR, et al.Human gut bacterial β-glucuronidase inhibition: an emerging approach to manage medication therapy. Biochem Pharmacol2021; 190: 114566.
42.
KingRJSinghPKMehlaK. The cholesterol pathway: impact on immunity and cancer. Trends Immunol2022; 43: 78–92.
43.
PrabhuAVLuuWSharpeLJ, et al.Cholesterol-mediated degradation of 7-dehydrocholesterol reductase switches the balance from cholesterol to vitamin D synthesis. J Biol Chem2016; 291: 8363–8373.
44.
PayneAHHalesDB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev2004; 25: 947–970.
45.
MotomuraNYamazakiYKogaD, et al.The association of cholesterol uptake and synthesis with histology and genotype in cortisol-producing adenoma (CPA). Int J Mol Sci2022; 23: 2174.
46.
WangHHLiTPortincasaP, et al.New insights into the role of Lith genes in the formation of cholesterol-supersaturated bile. Liver Res2017; 1: 42–53.
47.
ZampelasAMagriplisE. New insights into cholesterol functions: a friend or an enemy?Nutrients2019; 11: 1645.
48.
TabasI. Cholesterol in health and disease. J Clin Invest2002; 110: 583–590.
49.
ChoHJKimJDLeeWY, et al.Quantitative metabolic profiling of 21 endogenous corticosteroids in urine by liquid chromatography–triple quadrupole-mass spectrometry. Anal Chim Acta2009; 632: 101–108.
50.
KimSJJungHJChungBC, et al.Screening analysis of 10 adrenal steroids by matrix-assisted laser desorption ionization-tandem mass spectrometry. Mass Spectrom Lett2011; 2: 69–72.
51.
ZhengHYLiYDaiW, et al.Imbalance of testosterone/estradiol promotes male CHD development. Bio-Med Mater Eng2012; 22: 179–185.
XiaBShiXCXieBC, et al.Urolithin A exerts antiobesity effects through enhancing adipose tissue thermogenesis in mice. PLoS Biol2020; 18: e3000688.
54.
González-SarríasAGiménez-BastidaJANúñez-SánchezMÁ, et al.Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells. Eur J Nutr2014; 53: 853–864.
